Featuring keynote address by Nobel Laureate J. Michael Bishop, MD, followed by 6 sessions with plenary lectures and hot-topic presentations selected from abstract submissions, this 3-day conference will explore cancer as an individualized problem and address the impact of recent advances in cancer biology, genetics, tumor profiling, and medical technology in the personalization of cancer predisposition, diagnosis, prognosis, treatment, and therapy development.
The main goal of the conference is to foster dialogue among basic and clinical scientists working toward the personalization of cancer medicine and to encourage multidisciplinary collaborations. Furthermore, the experiences shared from different areas of individualized oncology will help improve the global concept of the personalized cancer care, and identify commonalities, pitfalls, and steps forward.
It is expected that the discussions originating from this symposium, their dissemination through enduring materials, and the collaborations emerging from this forum will ultimately generate comprehensive and cross-disciplinary approaches for the translation of our current knowledge of the molecular signatures of cancer into personalized therapies within the cancer care setting.
Accreditation for ESMO Members
This event has been accredited with 18 ESMO-MORA points Category 1. For more information about ESMO-MORA points, please visit the ESMO website.
For a complete list of sponsors, please click the Sponsorship tab.
Public Lecture: Cancer: Towards Personalized Medicine
May 18, 2010- CosmoCaixa Barcelona, 5:30 pm - 9:00 pm
As an introduction to this conference, and in an effort to disseminate the content of the program to a wider public, The New York Academy of Sciences, Fundació La Caixa, and Talència will hold this evening symposium open to the general public. In this open session, to be held at CosmoCaixa Barcelona, highlighted researchers and clinicians speaking at the scientific meeting will engage in an interactive discussion on what personalized cancer medicine means from a public prospective. So far, Laura van't Veer, PhD, and Nobel Laureate, J. Michael Bishop, MD, are already confirmed. For more information, please click here.
Eleventh Symposium organized by La Marato TV3 Foundation: Cancer, New Perspectives since the 2004 Telethon
May 17, 2010 – CosmoCaixa Barcelona, 9:00 am – 3:00 pm
Five years ago, TV3 dedicated its 2004 La Marato telethon to Cancer, raising close to 9 million Euros that were distributed among 31 investigators as research grants. On May 17, 2010, awardees, biomedical researches, and health-care professionals will convene to revise the scientific advancements and new discoveries resulting from those awarded project, and address their impact not only in the scientific community but in the society as a whole.